ATS 2018 Efficacy, Safety of Dupilumab in Corticosteroid-Dependent Severe Asthma Publish Date May 21, 2018 Subcutaneous dupilumab significantly reduced the use of oral corticosteroids in patients with corticosteroid-dependent severe asthma.
ATS 2018 Lung Function in Severe Asthma Improved With Benralizumab Publish Date May 20, 2018 Peak expiratory flow increases were greater with benralizumab than placebo in patients with severe eosinophilic asthma.
ATS 2019 PONENTE Trial May Provide Guidance for OCS Tapering in Asthma Publish Date May 20, 2019 Benralizumab has been found to be associated with a reduction in oral corticosteroid (OCS) use while maintaining asthma control for patients with OCS-dependent severe asthma.